In HCC, the expression and function of NDRG1 is controversial, but in prostate cancer, the gene expression in patients with lymph node or bone metastasis is significantly reduced compared with that in patients with localized prostate cancer (43). The gene discussed is NDRG1; the disease is hepatocellular carcinoma.